Noticias de KYMR_US

Noticias del mercado

Últimas noticias sobre KYMR_US — 219 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: KYMR_US ✕ 219 resultados
02/04/2026 KYMR_US — MarketBeat
Kymera Therapeutics (NASDAQ:KYMR) Director Sells $631,738.00 in Stock
02/04/2026 KYMR_US — MarketBeat
Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) COO Sells $1,251,134.40 in Stock
02/04/2026 KYMR_US — MarketBeat
Jeremy Chadwick Sells 7,600 Shares of Kymera Therapeutics (NASDAQ:KYMR) Stock
02/04/2026 KYMR_US — MarketBeat
Kymera Therapeutics (NASDAQ:KYMR) Director Elena Ridloff Sells 4,600 Shares
01/04/2026 KYMR_US — Stock Titan ES ← EN
Presentaciones presentadas ante la SEC de KYMR: Kymera Therapeutics, Inc. Formularios 10-K, 10-Q, 8-K
01/04/2026 KYMR_US — Stock Titan
Kymera Therapeutics (NASDAQ: KYMR) director sells 12,000 shares under 10b5-1 plan
01/04/2026 KYMR_US — Stock Titan
Kymera (KYMR) COO sells 22,240 shares after exercising options
01/04/2026 KYMR_US — Stock Titan
KYMR (NASDAQ) director/insider plans 4,600-share option exercise; prior 7,400-share 10b5-1 sale
01/04/2026 KYMR_US — Stock Titan
Form 144 and 10b5-1 sales reported for KYMR (NASDAQ: KYMR)
31/03/2026 KYMR_US — Stock Titan
[144] Kymera Therapeutics, Inc. SEC Filing
31/03/2026 KYMR_US — Stock Titan
[144] Kymera Therapeutics, Inc. SEC Filing
29/03/2026 KYMR_US — MarketBeat
JPMorgan Chase & Co. Lowers Stock Position in Kymera Therapeutics, Inc. $KYMR
28/03/2026 KYMR_US — Quiver Quantitative
Kymera Therapeutics Reports Positive Phase 1b Results for KT-621 in Atopic Dermatitis at AAD Annual Meeting
28/03/2026 KYMR_US — Investing News Network
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology Annual Meeting
27/03/2026 KYMR_US — Stock Titan
Kymera Therapeutics (KYMR) sets federal courts as exclusive forum for securities claims
27/03/2026 KYMR_US — Stock Titan
Vanguard Group (NYSE: V) reports 0 KYMR shares after realignment
25/03/2026 KYMR_US — MarketBeat ES ← EN
Jeremy Chadwick vende 24.727 acciones de Kymera Therapeutics (NASDAQ:KYMR)
25/03/2026 KYMR_US — MarketBeat ES ← EN
El director de operaciones de Kymera Therapeutics (NASDAQ:KYMR) vende acciones por valor de 7.063.662,50 dólares
25/03/2026 KYMR_US — MarketBeat ES ← EN
Las acciones de Kymera Therapeutics (NASDAQ:KYMR) suben un 8,4%: ¿qué sigue?
25/03/2026 KYMR_US — Stock Titan
Kymera Therapeutics (KYMR) COO sells 115,977 shares after option exercise

Página 10 de 11

keyboard_arrow_up